Results 141 to 150 of about 2,581 (157)

Measured fetal and neonatal exposure to Lumacaftor and Ivacaftor during pregnancy and while breastfeeding

Journal of Cystic Fibrosis, 2018
Charles Esther, Cameron Mckinzie, Elizabeth Stringer   +2 more
exaly  

Effects of Lumacaftor/Ivacaftor on physical activity and exercise tolerance in three adults with cystic fibrosis

Journal of Cystic Fibrosis, 2019
Daniela Savi, Paolo Palange, Stefano Schiavetto   +2 more
exaly  

Lumacaftor/Ivacaftor reduces pulmonary exacerbations in patients irrespective of initial changes in FEV1

Journal of Cystic Fibrosis, 2019
Claire Wainwright, Michael Konstan, Susanna Mccolley   +2 more
exaly  

Patent Review of Synthetic Routes and Crystalline Forms of the CFTR-Modulator Drugs Ivacaftor, Lumacaftor, Tezacaftor, and Elexacaftor

Organic Process Research and Development, 2019
David Hughes
exaly  

Efficacy of lumacaftor-ivacaftor for the treatment of cystic fibrosis patients homozygous for the F508del-CFTR mutation

Expert Review of Precision Medicine and Drug Development, 2016
Charles Esther, Deborah Cholon, Martina Gentzsch   +2 more
exaly  

Real-life initiation of lumacaftor/ivacaftor combination in adults with cystic fibrosis homozygous for the Phe508del CFTR mutation and severe lung disease

Journal of Cystic Fibrosis, 2017
Dominique Hubert, Prévotat Anne, Pierre Regis Burgel   +2 more
exaly  

Lumacaftor alone and combined with ivacaftor: preclinical and clinical trial experience of F508del CFTR correction

Expert Review of Respiratory Medicine, 2016
Gary Mcphail, John Clancy, John J Brewington   +2 more
exaly  

Isavuconazole/ivacaftor/lumacaftor

Reactions Weekly, 2019
openaire   +1 more source

Fluoxetine/ivacaftor/lumacaftor

Reactions Weekly, 2017
openaire   +1 more source

Ivacaftor/lumacaftor/tezacaftor

Reactions Weekly, 2019
openaire   +1 more source